Global Pharmaceutical Peptides Services Market 2025 by Company, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global Pharmaceutical Peptides Services market size was valued at US$ 5892 million in 2024 and is forecast to a readjusted size of USD 9673 million by 2031 with a CAGR of 7.4% during review period.

Pharmaceutical peptides services refer to the range of services offered by pharmaceutical companies or specialized service providers for the development, production, and analysis of peptides for therapeutic purposes. These services typically include:

1. Peptide synthesis: Custom synthesis of peptides based on specific requirements, including the design and production of peptide libraries.

2. Peptide modification: Chemical modification of peptides to enhance their stability, bioavailability, or target specificity.

3. Peptide purification: Purification of synthesized peptides to remove impurities and obtain high-quality products.

4. Peptide characterization: Comprehensive analysis of peptides using techniques such as mass spectrometry, high-performance liquid chromatography (HPLC), and nuclear magnetic resonance (NMR) spectroscopy to determine their identity, purity, and structural properties.

5. Peptide formulation: Development of peptide formulations suitable for various administration routes, such as oral, injectable, or topical delivery.

6. Peptide stability studies: Evaluation of the stability of peptides under different conditions, including temperature, pH, and storage conditions, to ensure their shelf-life and efficacy.

7. Peptide bioassays: Testing the biological activity and efficacy of peptides using in vitro and in vivo models to assess their therapeutic potential.

8. Peptide scale-up: Scaling up the production of peptides from laboratory-scale to commercial-scale manufacturing, ensuring consistent quality and quantity.

9. Regulatory support: Assistance in navigating regulatory requirements and guidelines for the development and approval of peptide-based therapeutics.

10. Contract research and manufacturing: Collaborative partnerships or outsourcing of peptide-related research, development, and manufacturing activities to specialized service providers.

These services are essential for the discovery, development, and production of peptide-based drugs, which have gained significant attention in the pharmaceutical industry due to their high specificity, low toxicity, and potential for targeting various diseases.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report is a detailed and comprehensive analysis for global Pharmaceutical Peptides Services market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Pharmaceutical Peptides Services market size and forecasts, in consumption value ($ Million), 2020-2031

Global Pharmaceutical Peptides Services market size and forecasts by region and country, in consumption value ($ Million), 2020-2031

Global Pharmaceutical Peptides Services market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031

Global Pharmaceutical Peptides Services market shares of main players, in revenue ($ Million), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Pharmaceutical Peptides Services

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Pharmaceutical Peptides Services market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Creative Peptides, AmbioPharm, 3B Pharmaceuticals, ISSAR Pharma, Peptide Institute, WuXi AppTec, JPT Peptide Technologies, CPC Scientific, Red Glead Discovery, Eurofins Scientific, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation

Pharmaceutical Peptides Services market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Peptide Drug Discovery
Peptide Drug Bioconjugations
Peptide Lead Optimization
Formulation Development
Peptide Drug Screening Service
Total Peptide Library Construction Technology
Other

Market segment by Application
Enterprise
Research Institute

Market segment by players, this report covers
Creative Peptides
AmbioPharm
3B Pharmaceuticals
ISSAR Pharma
Peptide Institute
WuXi AppTec
JPT Peptide Technologies
CPC Scientific
Red Glead Discovery
Eurofins Scientific
Bio-Synthesis
Bio Basic
CordenPharma

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Pharmaceutical Peptides Services product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Pharmaceutical Peptides Services, with revenue, gross margin, and global market share of Pharmaceutical Peptides Services from 2020 to 2025.

Chapter 3, the Pharmaceutical Peptides Services competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Pharmaceutical Peptides Services market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Pharmaceutical Peptides Services.

Chapter 13, to describe Pharmaceutical Peptides Services research findings and conclusion.